Related Experiment Video
Updated: Jun 6, 2026

07:46
Neurogenesis Using P19 Embryonal Carcinoma Cells
Published on: April 27, 2019
Natural progression of embryonal carcinoma
Ana López-González1, María Alejandra Egui Rojo, Constanza Maximiano
1Department of Urology, University Hospital Puerta de Hierro-Majadahonda, Madrid, Spain. alopgon2@hotmail.com
Archivos Espanoles De Urologia
|November 25, 2010
Summary
This case study details advanced testicular cancer progression without treatment and its successful chemotherapy response. It highlights the effectiveness of Bleomycin/Etoposide/Cisplatin in treating embryonal carcinoma.
Area of Science:
- Oncology
- Urology
Background:
- Testicular cancer is a rare but significant malignancy in young men.
- Early diagnosis and treatment are crucial for favorable outcomes.
Observation:
- A 37-year-old male with mental retardation presented with a scrotal ulcer, diagnosed as advanced pT4 embryonal carcinoma.
- CT scan revealed multiple lung metastases, indicating widespread disease.
Findings:
- The patient received five cycles of chemotherapy with Bleomycin/Etoposide/Cisplatin (BEP).
- Complete response was achieved post-treatment, demonstrating chemotherapy efficacy.
- The case illustrates the natural progression of untreated testicular cancer and its response to therapy.
Implications:
- This case underscores the importance of timely medical intervention for testicular cancer.
- Chemotherapy, specifically BEP, remains a highly effective treatment for advanced testicular tumors.
- Understanding the natural history of the disease aids in clinical management and patient counseling.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cleavage and Blastulation
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Embryonic Connective Tissues
During early development, the embryo forms two types of connective tissues— the mesenchyme and mucoid connective tissue.
The mesenchyme is the first connective tissue that emerges in the developing embryo. It consists of loosely arranged multipotent mesenchymal cells and reticular fibers in the extracellular matrix. This loose arrangement allows easy migration of cells, which is essential for germ layer positioning, patterning, and organ morphogenesis during embryonic development. Mesenchyme is...
The mesenchyme is the first connective tissue that emerges in the developing embryo. It consists of loosely arranged multipotent mesenchymal cells and reticular fibers in the extracellular matrix. This loose arrangement allows easy migration of cells, which is essential for germ layer positioning, patterning, and organ morphogenesis during embryonic development. Mesenchyme is...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

